Open AccessInfluence of isoprostane F2α-III on reflow after myocardial infarction
Author(s) -
Kim Greaves,
Simon R. Dixon,
Ivan O Brien Coker,
Anthony I. Mallet,
Metin Avkiran,
Michael J. Shattock,
Martin Fejka,
William W. O’Neill,
Roxy Senior,
Simon Redwood,
Michael Marber
Publication year - 2004
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1016/j.ehj.2004.03.015
Subject(s) - medicine , cardiology , myocardial infarction , isoprostane , oxidative stress , lipid peroxidation
To investigate whether the vasoconstrictor isoprostane F2alpha-III (iPF2alpha-III), released during myocardial reperfusion, contributes to the low/no reflow phenomenon observed following acute myocardial infarction (AMI).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom